Precision BioSciences Balance Sheet Health
Financial Health criteria checks 5/6
Precision BioSciences has a total shareholder equity of $18.9M and total debt of $22.4M, which brings its debt-to-equity ratio to 118.8%. Its total assets and total liabilities are $159.8M and $140.9M respectively.
Key information
118.8%
Debt to equity ratio
US$22.41m
Debt
Interest coverage ratio | n/a |
Cash | US$116.68m |
Equity | US$18.86m |
Total liabilities | US$140.92m |
Total assets | US$159.78m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PBS0's short term assets ($136.4M) exceed its short term liabilities ($50.0M).
Long Term Liabilities: PBS0's short term assets ($136.4M) exceed its long term liabilities ($90.9M).
Debt to Equity History and Analysis
Debt Level: PBS0 has more cash than its total debt.
Reducing Debt: PBS0's debt to equity ratio has increased from 0% to 118.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PBS0 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: PBS0 has sufficient cash runway for 1.5 years if free cash flow continues to grow at historical rates of 0.9% each year.